SCHEMBL13548632

SCHEMBL13548632

CC1CC(C)CN(C2CCN(c3ccc4[nH]c(-c5n[nH]c6cc(Cl)ccc56)nc4c3)CC2)C1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 11/20 0.53
FLT1 P17948 10/20 0.53
KDR P35968 1/20 0.53
ABL1 P00519 13/20 0.51
BCR P11274 4/20 0.44
PDPK1 O15530 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3534487 0.88 FGFR1 (0.65) FGFR1FLT1KDRABL1BCR
SCHEMBL5866881 0.88 FGFR1 (0.67) FGFR1FLT1KDRABL1BCR
SCHEMBL3536436 0.88 FGFR1 (0.57) FGFR1FLT1KDRABL1BCR
SCHEMBL3539570 0.88 FGFR1 (0.66) FGFR1FLT1KDRABL1BCR
SCHEMBL3539015 0.85 FGFR1 (0.55) FGFR1FLT1KDRABL1BCR
SCHEMBL3537562 0.84 FGFR1 (0.61) FGFR1FLT1KDRABL1BCR
SCHEMBL3536381 0.83 FGFR1 (0.57) FGFR1FLT1KDRABL1BCR
SCHEMBL3539963 0.83 FGFR1 (0.49) FGFR1FLT1KDRABL1PDPK1
SCHEMBL5866856 0.82 ABL1 (0.66) FGFR1FLT1KDRABL1BCR
SCHEMBL3539063 0.81 ABL1 (0.58) FGFR1FLT1KDRABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 US disclosed
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 US disclosed